SMA
Clinical trials for SMA explained in plain language.
Never miss a new study
Get alerted when new SMA trials appear
Sign up with your email to follow new studies for SMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for SMA patients: early access to apitegromab
Disease control NO_LONGER_AVAILABLEThis program gives eligible patients with spinal muscular atrophy (SMA) early access to the investigational drug apitegromab before it is officially approved. Participants must be at least 2 years old and have a confirmed SMA diagnosis. A doctor will decide if the potential benef…
Matched conditions: SMA
Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for SMA: experimental drug aims to boost muscle strength
Disease control OngoingThis study tests whether adding taldefgrobep alfa to standard SMA treatments can improve muscle function in people with spinal muscular atrophy. About 269 participants, both walkers and non-walkers, will receive either the drug or a placebo for 48 weeks. The main goal is to see i…
Matched conditions: SMA
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC